Table 2.
Changes in levels of cardiac function before and after four weeks treatment between the TEA group and control group
| GROUP | LVEDD (mm) | 95% CI | EF (%) | 95% CI | FS (%) | 95% CI | NYHA | 95% CI |
|---|---|---|---|---|---|---|---|---|
|
Control group |
|
|
|
|
|
|
|
|
| Pre-treatment |
64.85 ± 5.86 |
(53.56-76.13) |
32.45 ± 7.21 |
(18.31-46.59) |
25.80 ± 5.73 |
(14.56-37.04) |
3.65 ± 0.48 |
(2.69-4.61) |
| post-treatment |
63.15 ± 5.23 |
(52.89-73.40) |
33.15 ± 5.98 |
(21.44-44.86) |
26.61 ± 5.52 |
(15.73-37.37) |
3.3 ± 0.8 |
(1.73-4.87) |
|
Chang |
1.65 ± 0.64 |
|
0.55 ± 0.38 |
|
0.85 ± 0.61 |
|
0.35 ± 0.10 |
|
|
TEA group |
|
|
|
|
|
|
|
|
| Pre-treatment |
66.45 ± 5.28 |
(56.08-76.80) |
30.35 ± 6.78 |
(13.23-46.78) |
24.20 ± 3.54 |
(17.24-31.15) |
3.75 ± 0.44 |
(2.87-4.62) |
| post-treatment |
58.30 ± 5.38 |
(47.75-68.64) |
34.15 ± 6.12 |
(16.39-50.42) |
28.15 ± 4.67 |
(18.99-37.30) |
2.55 ± 0.76 |
(1.06-4.04) |
| Chang | 8.15 ± 0.65** | 3.80 ± 0.56** | 3.95 ± 0.62** | 1.2 ± 0.16** |
Significant differences were performed using a two-tailed paired Student t test. (**: p<0.001, vs. control group).